Chemotherapy-related cognitive impairment and non-pharmacological interventions targeting the nervous system: a systematic review - Report - MDSpire

Chemotherapy-related cognitive impairment and non-pharmacological interventions targeting the nervous system: a systematic review

  • By

  • Norbert Dosa

  • Intouch Limvaree

  • Camila Bonin Pinto

  • Faddi Saleh Velez

  • Zalan Kaposzta

  • Zsofia Szarvas

  • Zachary C. Pope

  • Anna Csiszar

  • Wajeeha Razaq

  • Ryan D. Nipp

  • Andriy Yabluchanskiy

  • Peter Mukli

  • June 2, 2026

  • 0 min

Share

Clinical Report: Cognitive Dysfunction Associated with Chemotherapy

Overview

This systematic review highlights the prevalence of chemotherapy-related cognitive impairment (CRCI) among cancer survivors and evaluates non-pharmacological interventions aimed at improving cognitive function. Mild improvements in cognitive outcomes were observed across various studies, though limitations in study design were noted.

Background

Chemotherapy-related cognitive impairment (CRCI) is a significant concern for cancer survivors, affecting memory, attention, and executive function, which can severely impact quality of life. With the increasing number of cancer survivors, understanding and addressing CRCI is crucial for enhancing survivorship care. Non-pharmacological interventions may offer promising avenues for mitigating these cognitive deficits.

Data Highlights

No numerical data available; findings are qualitative in nature.

Key Findings

  • CRCI affects both subjective and objective cognitive measures in cancer survivors.
  • Seventeen studies met inclusion criteria, including nine randomized controlled trials.
  • Interventions included transcranial direct current stimulation, acupuncture, and multisensory stimulation.
  • Mild improvements in cognitive outcomes were reported, but studies had limitations such as small sample sizes and lack of control groups.
  • There is a need for larger, well-designed trials to validate the efficacy of non-pharmacological interventions for CRCI.

Clinical Implications

Healthcare professionals should be aware of the cognitive challenges faced by cancer survivors and consider non-pharmacological interventions as part of survivorship care. Further research is needed to establish effective strategies for mitigating CRCI and improving quality of life.

Conclusion

The review underscores the importance of addressing CRCI in cancer survivors and the potential role of non-pharmacological interventions, while highlighting the need for more robust clinical trials to confirm these findings.

Related Resources & Content

  1. NCCN Guidelines® Insights, Version 2.2025 -- Survivorship
  2. Effects of Exercise on Cognitive Impairment in Patients Receiving Chemotherapy -- PubMed
  3. The ASCO Post — Cognitive Impairment in Patients with Cancer
  4. The ASCO Post — Cognitive Impairment in Patients with Cancer
  5. The ASCO Post — Cognitive Impairment in Patients with Cancer
  6. The ASCO Post — Cognitive Impairment in Patients with Cancer
  7. Cognitive Impairment in Patients with Cancer
  8. NCCN Guidelines® Insights: Survivorship, Version 2.2025 - PubMed
  9. Effects of Exercise on Cognitive Impairment in Patients Receiving Chemotherapy: A Multicenter Phase III Randomized Controlled Trial - PubMed

Original Source(s)

Related Content